PUBLIC CONTRACT · 2018
07/81365.11/2018 - Aq. “Sofosbuvir 400 mg + Velpatasvir 100 mg Comp” e “Glecaprevir 100 mg + Pibrentasvir 40 mg Comp” – Hepatite C Crónica
- Contract value
- €460,336.57
- Signed on
- 18 May 2018
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4548950PUBLISHED SUBJECT
Aquisição dos medicamentos “Sofosbuvir 400 mg + Velpatasvir 100 mg Comp” e “Glecaprevir 100 mg + Pibrentasvir 40 mg Comp” – Hepatite C Crónica
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Aveiro, Santa Maria da Feira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Pfizer Biofarmaceutica, Sociedade Unipessoal Lda. · Tax ID 513300376
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €460,336.57
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 14 June 2018
- Award date
- 9 May 2018
- Signing date
- 18 May 2018
- Performance period
- 226 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3436625
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.